Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36901 - 36925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	CUBN	8029	upregulated	entinostat results in increased expression of CUBN mRNA	10p13	A21035
Entinostat	Investigational	CUL3	8452	downregulated	entinostat results in decreased expression of CUL3 mRNA	2q36.2	A21037
Entinostat	Investigational	CUZD1	50624	upregulated	entinostat results in increased expression of CUZD1 mRNA	10q26.13	A21037
Entinostat	Investigational	CX3CR1	1524	upregulated	entinostat results in increased expression of CX3CR1 mRNA	3p22.2	A21035
Entinostat	Investigational	CXCL10	3627	upregulated	entinostat results in increased expression of CXCL10 mRNA	4q21.1	A21035
Entinostat	Investigational	CXCL12	6387	upregulated	entinostat results in increased expression of CXCL12 mRNA	10q11.21	A21037
Entinostat	Investigational	CXCL5	6374	upregulated	entinostat results in increased expression of CXCL5 mRNA	4q13.3	A21037
Entinostat	Investigational	CXCR4	7852	downregulated	entinostat results in decreased expression of CXCR4 mRNA	2q22.1	A21037
Entinostat	Investigational	CXXC4	80319	downregulated	entinostat results in decreased expression of CXXC4 mRNA	4q24	A21037
Entinostat	Investigational	CXXC5	51523	upregulated	entinostat results in increased expression of CXXC5 mRNA	5q31.2	A21037
Entinostat	Investigational	CYB561	1534	upregulated	entinostat results in increased expression of CYB561 mRNA	17q23.3	A21037
Entinostat	Investigational	CYBRD1	79901	upregulated	entinostat results in increased expression of CYBRD1 mRNA	2q31.1	A21035
Entinostat	Investigational	CYFIP1	23191	downregulated	entinostat results in decreased expression of CYFIP1 mRNA	15q11.2	A21037
Entinostat	Investigational	CYP1A1	1543	upregulated	entinostat results in increased expression of CYP1A1 mRNA	15q24.1	A21037
Entinostat	Investigational	CYP24A1	1591	upregulated	entinostat results in increased expression of CYP24A1 mRNA	20q13.2	A21035
Entinostat	Investigational	CYP26A1	1592	upregulated	entinostat results in increased expression of CYP26A1 mRNA	10q23.33	A21037
Entinostat	Investigational	CYP27C1	339761	downregulated	entinostat results in decreased expression of CYP27C1 mRNA	2q14.3	A21035
Entinostat	Investigational	CYP2S1	29785	upregulated	entinostat results in increased expression of CYP2S1 mRNA	19q13.2	A21037
Entinostat	Investigational	CYP4X1	260293	upregulated	entinostat results in increased expression of CYP4X1 mRNA	1p33	A21037
Entinostat	Investigational	CYSTM1	84418	upregulated	entinostat results in increased expression of CYSTM1 mRNA	5q31.3	A21035
Entinostat	Investigational	CYTH1	9267	downregulated	entinostat results in decreased expression of CYTH1 mRNA	17q25.3	A21035
Entinostat	Investigational	DAAM2	23500	upregulated	entinostat results in increased expression of DAAM2 mRNA	6p21.2	A21035
Entinostat	Investigational	DACH1	1602	downregulated	entinostat results in decreased expression of DACH1 mRNA	13q21.33	A21037
Entinostat	Investigational	DACT1	51339	upregulated	entinostat results in increased expression of DACT1 mRNA	14q23.1	A21037
Entinostat	Investigational	DAZAP2	9802	upregulated	entinostat results in increased expression of DAZAP2 mRNA	12q13.13	A21035

Displaying entries 36901 - 36925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability